Improving the TRIcycle protocol: upscaling to national Monitoring, detection of CPE and WGS pipelines for One Health Surveillance
Environment
Surveillance
- Heike Schmitt, National Institute for Public Health and the Environment (RIVM), Netherlands (Coordinator)
- Laurence Armand-Lefevre, University Paris-Diderot Medical School, INSERM, France (Partner)
- Luc Samison, University of Antananarivo, Madagascar (Partner)
- Rohaidah Hashim, Institute for Medical Research, Malaysia (Partner)
- Jaap Wagenaar, Utrecht University, Netherlands (Partner)
- Muhammad Salman, National Institute of Health (NIH), Pakistan (Partner)
Antibiotic resistance circulates in humans, and also in animals and the environment. Knowledge on the presence of resistant bacteria in all three domains is therefore needed to combat the adverse health effects of antibiotic resistance. However, there is little guidance on how to achieve such a One Health surveillance. In the TRIuMPH project, protocols are established to monitor the presence of carbapenemase producing Enterobacterales (CPE), which are particularly concerning antibiotic resistant bacteria. These protocols are applicable to humans, animals and the environment, and can be used globally. These protocols are then implemented and tested in Madagascar, Malaysia, and Pakistan. Next to CPE, ESBL producing E. coli are also analysed using the WHO Tricycle protocol. With whole genome sequencing, the relation between strains found in the three domains will be explored based on openly available tools. Further, extension of current wastewater based surveillance systems to include analysis of resistant bacteria will be tested. These activities help to identify success factors for implementation of One Health surveillance.